Betoptic S Suspension/ Drops
Product Images NDC 0078-0729

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Betoptic S (NDC 0078-0729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel Ndc 0078-0729-10 Betoptic S® (betaxolol Hci Ophthalmic Suspension) 0.25% As Base 10 mL Sterile Novartis (Carton)

Principal Display Panel									Ndc 0078-0729-10									Betoptic S®									(betaxolol Hci Ophthalmic Suspension) 0.25% As Base									10 mL Sterile									Novartis (Carton)
Betoptic S is an ophthalmic suspension containing 0.25% betaxolol HCI as a base, used for topical application in the eyes. The solution is sterile, and each mL contains 0.019% of inactive ingredients. The product is manufactured by Aoon Laboratories and is distributed by Novartis Pharmaceuticals Corporation. It comes in a 10mL sterile bottle and should be stored at 25°C. The product is available by prescription only, and the GTIN is 0300780720109.*
FDA Label Image

Chemical (Chemical)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.